Skip to content
Buy 1 Get 1 Free or 33% off You choose in the cart · Ends in --d --h --m --s Shop the sale
Free ground shipping on $149.99+ · free priority on $219.99+
Research Comparison

Tesamorelin vs Ipamorelin

Last updated · By Prime Peptide Solutions · Editorial policy

Tesamorelin and Ipamorelin are both investigated in growth hormone-axis research, but they act on different receptors and produce different research profiles. Tesamorelin is a GHRH analog; Ipamorelin is a ghrelin-receptor agonist. Researchers often weigh the two when designing studies around growth hormone pulsatility or visceral adipose tissue.

Tesamorelin · 10mg
Regular price $69.99 Now $46.89 COA
View product
Ipamorelin · 10MG
Regular price $54.99 Now $36.84 COA
View product
PropertyTesamorelinIpamorelin
ClassGHRH analogGHRP (ghrelin-receptor agonist)
ReceptorGHRH receptor (pituitary)Ghrelin / GHS receptor
Primary research focusVisceral adipose tissue, lipid markersGH pulse, selective GH release
Selectivity (research)GH-specific via GHRHMinimal cortisol/prolactin effect
Half-life (reported)~26 minutes~2 hours

About Tesamorelin

Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH). Research has primarily characterized it for effects on visceral adipose tissue and lipid markers in animal and clinical research models. It stimulates endogenous growth hormone release through GHRH receptor activation rather than introducing exogenous growth hormone directly.

About Ipamorelin

Ipamorelin is a pentapeptide and selective ghrelin-receptor agonist. Research literature characterizes it for its selectivity profile -- specifically that it has been investigated for growth hormone release without significant effect on cortisol or prolactin in research models. It is often grouped with other GHRPs (growth hormone releasing peptides).

Which Should Researchers Choose?

The choice depends on the research mechanism of interest:

  • GHRH-axis research -> Tesamorelin.
  • Selective GH-pulse research -> Ipamorelin.
  • Combined GHRH + GHRP research -> Many protocols pair Tesamorelin or CJC-1295 with Ipamorelin to study synergistic GH release.

Frequently Asked Questions

Are these the same class of peptide?

No. Tesamorelin is a GHRH analog; Ipamorelin is a ghrelin-receptor agonist (GHRP).

Why are they often discussed together?

Both are investigated for growth hormone release but act through distinct receptors, so research protocols sometimes pair them.

Are these FDA approved?

Tesamorelin has clinical research history. Ipamorelin remains an investigational compound. Neither is approved for general human consumption outside of research.

Shop these products

Tesamorelin · 10mg
Regular price $69.99 Now $46.89
Ipamorelin · 10MG
Regular price $54.99 Now $36.84
For laboratory research use only.
For research use only. Not for human or veterinary use. All products and content are intended strictly for laboratory research. The information provided is summarized from published research literature. Editorial policy

Other Comparisons